Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans

Por Hudachek, Susan F., Gustafson, Daniel L.
Publicado em 2013

Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice

Por Hudachek, Susan F., Gustafson, Daniel L.
Publicado no J Pharmacokinet Pharmacodyn (2013)

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice

Por Denton, Cathrine L., Gustafson, Daniel L.
Publicado no Cancer Chemother Pharmacol (2010)

Coadministration of lapatinib increases exposure to docetaxel but not doxorubicin in the small intestine of mice

Por Hudachek, Susan F., Gustafson, Daniel L.
Publicado no Anticancer Drugs (2013)

Autophagy and Cancer Therapy

Por Thorburn, Andrew, Thamm, Douglas H., Gustafson, Daniel L.
Publicado em 2014

Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid/Doxorubicin Treatment in Dogs with Spontaneous Cancer

Por Wittenburg, Luke A., Gustafson, Daniel L., Thamm, Douglas H.
Publicado em 2010

Rapid and sensitive LC–MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma

Por Hansen, Ryan J., Samber, Bradley J., Gustafson, Daniel L.
Publicado no J Chromatogr B Analyt Technol Biomed Life Sci (2010)

Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy

Por Gustafson, Daniel L., Fowles, Jared S., Brown, Kristen C., Theodorescu, Dan
Publicado no Assay Drug Dev Technol (2015)

Pharmacokinetic-Directed Dosing of Vandetanib and Docetaxel in a Mouse Model of Human Squamous Cell Carcinoma

Por Bradshaw-Pierce, Erica L., Steinhauer, Courtney A., Raben, David, Gustafson, Daniel L.
Publicado em 2008

Expression of Human NAD(P)H:Quinone Oxidoreductase (DT-Diaphorase) in Chinese Hamster Ovary Cells: Effect on the Toxicity of Antitumor Quinones

Por GUSTAFSON, DANIEL L., BEALL, HOWARD D., BOLTON, EMIKO M., ROSS, DAVID, WALDREN, CHARLES A.
Publicado em 1996

Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma

Por Fowles, Jared S., Brown, Kristen C., Hess, Ann M., Duval, Dawn L., Gustafson, Daniel L.
Publicado no BMC Bioinformatics (2016)

Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity

Por Mitchell, Leah A., Hansen, Ryan J., Beaupre, Adam J., Gustafson, Daniel L., Dow, Steven W.
Publicado em 2012

Pharmacokinetics of Sustained-Release Analgesics in Mice

Por Kendall, Lon V, Hansen, Ryan J, Dorsey, Kathryn, Kang, Sooah, Lunghofer, Paul J, Gustafson, Daniel L
Publicado em 2014

Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease

Por Barnard, Rebecca A., Regan, Daniel P., Hansen, Ryan J., Maycotte, Paola, Thorburn, Andrew, Gustafson, Daniel L.
Publicado no J Pharmacol Exp Ther (2016)

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

Por Barnard, Rebecca A, Wittenburg, Luke A, Amaravadi, Ravi K, Gustafson, Daniel L, Thorburn, Andrew, Thamm, Douglas H
Publicado em 2014

Structure–activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model()

Por Wong, O. Andrea, Hansen, Ryan J., Ni, Thomas W., Heinecke, Christine L., Compel, W. Scott, Gustafson, Daniel L., Ackerson, Christopher J.
Publicado em 2013

Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomas

Por Venable, Rachel O., Worley, Deanna R., Gustafson, Daniel L., Hansen, Ryan J., Ehrhart, E. J., Cai, Shuang, Cohen, Mark S., Forrest, M. Laird
Publicado em 2012

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors

Por Lam, Elaine T., O'Bryant, Cindy L., Basche, Michele, Gustafson, Daniel L., Serkova, Natalie, Baron, Anna, Holden, Scott N., Dancey, Janet, Eckhardt, S. Gail, Gore, Lia
Publicado em 2008

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor

Por Halsey, Charles HC, Gustafson, Daniel L, Rose, Barbara J, Wolf-Ringwall, Amber, Burnett, Robert C, Duval, Dawn L, Avery, Anne C, Thamm, Douglas H
Publicado em 2014

Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer

Por Bradshaw-Pierce, Erica L., Pitts, Todd M., Kulikowski, Gillian, Selby, Heather, Merz, Andrea L., Gustafson, Daniel L., Serkova, Natalie J., Eckhardt, S. Gail, Weekes, Colin D.
Publicado em 2013